Related Experiment Video
Updated: Sep 13, 2025
10:13
Author Spotlight: An Efficient Methodology to Confidently Differentiate and Characterize Fentanyl Analogs
Published on: November 8, 2024
2.4K
Severe Fentanyl Withdrawal Associated With Medetomidine Adulteration: A Multicenter Study From Philadelphia, PA
Journal of Addiction Medicine
|August 1, 2025
Summary
Medetomidine adulteration in fentanyl causes severe withdrawal, distinct from opioid withdrawal. Aggressive therapies like dexmedetomidine are needed for these patients.
Area of Science:
- Pharmacology
- Toxicology
- Emergency Medicine
Background:
- Medetomidine, a veterinary alpha2-adrenergic agonist, is increasingly found as an adulterant in illicit fentanyl.
- This adulteration is associated with a severe withdrawal syndrome, differing from typical opioid withdrawal.
Purpose of the Study:
- To describe the clinical characteristics and outcomes of patients experiencing withdrawal from medetomidine-adulterated fentanyl.
- To highlight the limitations of standard opioid withdrawal management in this context.
Main Methods:
- A multicenter case series of 209 patients in Philadelphia between September 2024 and April 2025.
- Inclusion criteria: reported opioid use, opioid withdrawal complicated by severe sympathetic activation, and hospitalization.
- Data included demographics, clinical outcomes, and toxicology testing in a subset.
Main Results:
- 77.5% of patients required ICU admission, and 20.1% needed intubation.
- Traditional opioid withdrawal management was often ineffective; 73.7% received dexmedetomidine infusion.
- Toxicology confirmed fentanyl and medetomidine in 100% of tested patients (n=43). Severe complications included encephalopathy (35.4%) and myocardial injury (28.7%).
Conclusions:
- Medetomidine-adulterated fentanyl exposure leads to severe withdrawal syndromes requiring specialized management.
- Clinicians must recognize the inadequacy of standard protocols and consider aggressive alpha2-agonist therapies like dexmedetomidine.
- Adapting clinical and public health strategies is crucial as medetomidine adulteration potentially increases.
More Related Videos
Related Concept Videos
01:15Opioid Analgesics: Synthetic and Semisynthetic Opioids
437
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
437
01:24Parenteral Anesthetics: Overview
199
Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
199
01:17Sedatives and Hypnotics Drugs: Miscellaneous Agents
243
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
243
01:20Opioid Analgesics: Morphine and Other Natural Cogeners
366
Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
366
01:25Analgesia and Pain Management
803
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
803
01:15Drug Abuse and Addiction: Pharmacological Phenomena
656
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
656